JP2018530582A5 - - Google Patents

Download PDF

Info

Publication number
JP2018530582A5
JP2018530582A5 JP2018519276A JP2018519276A JP2018530582A5 JP 2018530582 A5 JP2018530582 A5 JP 2018530582A5 JP 2018519276 A JP2018519276 A JP 2018519276A JP 2018519276 A JP2018519276 A JP 2018519276A JP 2018530582 A5 JP2018530582 A5 JP 2018530582A5
Authority
JP
Japan
Prior art keywords
substituted
halo
alkyl
compound according
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018519276A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018530582A (ja
JP6843853B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/056716 external-priority patent/WO2017066368A1/en
Publication of JP2018530582A publication Critical patent/JP2018530582A/ja
Publication of JP2018530582A5 publication Critical patent/JP2018530582A5/ja
Application granted granted Critical
Publication of JP6843853B2 publication Critical patent/JP6843853B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018519276A 2015-10-14 2016-10-13 選択的nr2bアンタゴニスト Expired - Fee Related JP6843853B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3309/DEL/2015 2015-10-14
IN3309DE2015 2015-10-14
PCT/US2016/056716 WO2017066368A1 (en) 2015-10-14 2016-10-13 Selective nr2b antagonists

Publications (3)

Publication Number Publication Date
JP2018530582A JP2018530582A (ja) 2018-10-18
JP2018530582A5 true JP2018530582A5 (OSRAM) 2019-11-21
JP6843853B2 JP6843853B2 (ja) 2021-03-17

Family

ID=57208377

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018519276A Expired - Fee Related JP6843853B2 (ja) 2015-10-14 2016-10-13 選択的nr2bアンタゴニスト

Country Status (13)

Country Link
US (2) US10501451B2 (OSRAM)
EP (1) EP3362447B1 (OSRAM)
JP (1) JP6843853B2 (OSRAM)
KR (1) KR20180064507A (OSRAM)
CN (1) CN108368101B (OSRAM)
AU (1) AU2016340239A1 (OSRAM)
BR (1) BR112018007181A2 (OSRAM)
CA (1) CA3001894A1 (OSRAM)
EA (1) EA201890764A1 (OSRAM)
ES (1) ES2822830T3 (OSRAM)
IL (1) IL258611A (OSRAM)
MX (1) MX2018004257A (OSRAM)
WO (1) WO2017066368A1 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017066366A1 (en) * 2015-10-14 2017-04-20 Bristol-Myers Squibb Company Selective nr2b antagonists
JP7093469B2 (ja) * 2018-10-17 2022-06-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 4-ピリジニルメチル-モルホリン誘導体および医薬としてのその使用
WO2020079040A1 (en) * 2018-10-17 2020-04-23 Boehringer Ingelheim International Gmbh 4-pyrimidin-5-ylmethyl-morpholine derivatives and the use thereof as medicament
US11166958B2 (en) * 2018-10-17 2021-11-09 Boehringer Ingelheim International Gmbh 4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament
EP3980420B1 (en) 2019-06-04 2023-04-19 Boehringer Ingelheim International GmbH Imidazopyrazine derivatives and the use thereof as medicament
KR20230116865A (ko) * 2020-12-04 2023-08-04 노파르티스 아게 우울증의 치료를 위한 nr2b-nmda 수용체 nam의 투여요법
CN113620896A (zh) * 2021-08-31 2021-11-09 青岛科技大学 2-(2-氯苯基)甲基-4,4-二甲基-3-异恶唑酮的制备方法
CN116063200A (zh) * 2022-12-12 2023-05-05 华南理工大学 一种异噁唑啉宠物用杀虫剂氟雷拉纳中间体及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476041B1 (en) 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
US7022728B2 (en) 2001-03-09 2006-04-04 Abbott Laboratories Benzimidazoles that are useful in treating male sexual dysfunction
JPWO2003035641A1 (ja) 2001-10-22 2005-02-10 塩野義製薬株式会社 新規カルバモイルピロリドン誘導体
EP1648882B1 (en) 2003-06-04 2008-08-06 Merck & Co., Inc. 3-fluoro-piperidines as nmda/nr2b antagonists
JP2007508288A (ja) 2003-10-08 2007-04-05 ファイザー株式会社 縮合ラクタム化合物
US20070185168A1 (en) * 2004-04-07 2007-08-09 Takai Haruki S Piperidine derivatives
WO2006137465A1 (ja) * 2005-06-24 2006-12-28 Shionogi & Co., Ltd. 含窒素複素環誘導体
EP1988077A4 (en) 2006-02-23 2009-09-02 Shionogi & Co NUCLEIC HETEROCYCLIC DERIVATIVES SUBSTITUTED BY CYCLIC GROUPS
KR20100045983A (ko) 2007-06-29 2010-05-04 에모리 유니버시티 신경보호를 위한 nmda 수용체 길항물질
JP2009067784A (ja) * 2007-08-21 2009-04-02 Shionogi & Co Ltd 環式基で置換された含窒素複素環誘導体を含有する鎮痛剤
CN102933226A (zh) * 2010-02-11 2013-02-13 西北大学 二级结构稳定化的nmda受体调节剂及其用途
US9221796B2 (en) 2014-01-09 2015-12-29 Bristol-Myers Squibb Company Selective NR2B antagonists
US9187506B2 (en) * 2014-01-09 2015-11-17 Bristol-Myers Squibb Company (R)-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one and its prodrugs for the treatment of psychiatric disorders

Similar Documents

Publication Publication Date Title
JP2018530582A5 (OSRAM)
JP2013537203A5 (OSRAM)
JP2016506960A5 (OSRAM)
JP2019513778A5 (OSRAM)
JP2016505614A5 (OSRAM)
JP2020502092A5 (OSRAM)
JP2019518766A5 (OSRAM)
JP2013544846A5 (OSRAM)
JP2014504646A5 (OSRAM)
JP2008533191A5 (OSRAM)
JP2006524660A5 (OSRAM)
JP2015509534A5 (OSRAM)
JP2017533968A5 (OSRAM)
JP2016534134A5 (OSRAM)
RU2016118768A (ru) Композиции, пригодные для лечения расстройств, связанных с kit
JP2016529324A5 (OSRAM)
JP2017504635A5 (OSRAM)
JP2015509535A5 (OSRAM)
JP2017538773A5 (OSRAM)
JP2012510502A5 (OSRAM)
SI2743266T1 (en) Protein kinase inhibitors (variants), their use in the treatment of oncological diseases and the pharmaceutical composition on their basis
JP2013544860A5 (OSRAM)
JP2016503797A5 (OSRAM)
JP2011513410A5 (OSRAM)
JP2013536188A5 (OSRAM)